Cargando…
Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives
Prostate cancer (PCa) is the second most frequently diagnosed cancer in men. Despite the significant progress in cancer diagnosis and treatment over the last few years, the approach to disease detection and therapy still does not include histopathological biomarkers. The dissemination of PCa is stri...
Autores principales: | Kiełb, Paweł, Kowalczyk, Kamil, Gurwin, Adam, Nowak, Łukasz, Krajewski, Wojciech, Sosnowski, Roman, Szydełko, Tomasz, Małkiewicz, Bartosz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295349/ https://www.ncbi.nlm.nih.gov/pubmed/37371647 http://dx.doi.org/10.3390/biomedicines11061552 |
Ejemplares similares
-
Alternatives for MRI in Prostate Cancer Diagnostics—Review of Current Ultrasound-Based Techniques
por: Gurwin, Adam, et al.
Publicado: (2022) -
Comparative analysis of GOLPH3 expression in lymph node-positive prostate cancer: immunohistochemistry staining patterns and clinical significance
por: Kiełb, Paweł, et al.
Publicado: (2023) -
Diagnostic Value of the Sentinel Lymph Node Technique in Patients with Muscle-Invasive Bladder Cancer
por: Małkiewicz, Bartosz, et al.
Publicado: (2023) -
Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?
por: Małkiewicz, Bartosz, et al.
Publicado: (2022) -
Role of IL-17A and IL-17RA in Prostate Cancer with Lymph Nodes Metastasis: Expression Patterns and Clinical Significance
por: Kiełb, Paweł, et al.
Publicado: (2023)